Jin K - Search Results

1

Sunitinib is effective and tolerable in Chinese patients with advanced pancreatic neuroendocrine tumors: a multicenter retrospective study in China.

Wang Y, Jin K, Tan H, Zhang P, Yang Q, Wang W, Li J, Shao C, Xue L, Feng S, Chen M, Yu X, Chen J. Wang Y, et al. Among authors: jin k. Cancer Chemother Pharmacol. 2017 Sep;80(3):507-516. doi: 10.1007/s00280-017-3367-9. Epub 2017 Jul 13. Cancer Chemother Pharmacol. 2017. PMID: 28707013

2

(18)F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumors.

Luo G, Liu Z, Guo M, Jin K, Xiao Z, Liu L, Xu J, Zhang B, Liu C, Huang D, Hu S, Ni Q, Long J, Yu X. Luo G, et al. Among authors: jin k. Int J Oncol. 2014 Oct;45(4):1531-6. doi: 10.3892/ijo.2014.2570. Epub 2014 Jul 29. Int J Oncol. 2014. PMID: 25096059

3

Blood neutrophil-lymphocyte ratio predicts survival in patients with advanced pancreatic cancer treated with chemotherapy.

Luo G, Guo M, Liu Z, Xiao Z, Jin K, Long J, Liu L, Liu C, Xu J, Ni Q, Yu X. Luo G, et al. Among authors: jin k. Ann Surg Oncol. 2015 Feb;22(2):670-6. doi: 10.1245/s10434-014-4021-y. Epub 2014 Aug 26. Ann Surg Oncol. 2015. PMID: 25155401

4

Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer.

Jin K, Luo G, Xiao Z, Liu Z, Liu C, Ji S, Xu J, Liu L, Long J, Ni Q, Yu X. Jin K, et al. Drug Des Devel Ther. 2015 Feb 26;9:1247-55. doi: 10.2147/DDDT.S77597. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 25750521 Free PMC article. Review.

5

Lymph node status predicts the benefit of adjuvant chemoradiotherapy for patients with resected pancreatic cancer.

Liu Z, Luo G, Guo M, Jin K, Xiao Z, Liu L, Liu C, Xu J, Ni Q, Long J, Yu X. Liu Z, et al. Among authors: jin k. Pancreatology. 2015 May-Jun;15(3):253-8. doi: 10.1016/j.pan.2015.03.012. Epub 2015 Apr 2. Pancreatology. 2015. PMID: 25921232

6

A comprehensive comparison of clinicopathologic and imaging features of incidental/symptomatic non-functioning pancreatic neuroendocrine tumors: A retrospective study of a single center.

Luo G, Liu Z, Guo M, Jin K, Xiao Z, Liu L, Liu C, Xu J, Ni Q, Long J, Yu X. Luo G, et al. Among authors: jin k. Pancreatology. 2015 Sep-Oct;15(5):519-524. doi: 10.1016/j.pan.2015.08.009. Epub 2015 Sep 3. Pancreatology. 2015. PMID: 26365059

7

ALDOA functions as an oncogene in the highly metastatic pancreatic cancer.

Ji S, Zhang B, Liu J, Qin Y, Liang C, Shi S, Jin K, Liang D, Xu W, Xu H, Wang W, Wu C, Liu L, Liu C, Xu J, Ni Q, Yu X. Ji S, et al. Among authors: jin k. Cancer Lett. 2016 Apr 28;374(1):127-135. doi: 10.1016/j.canlet.2016.01.054. Epub 2016 Feb 12. Cancer Lett. 2016. PMID: 26854714

8

Roux-en-Y pancreaticojejunostomy reconstruction after deep enucleation of benign or borderline pancreatic lesions: a single-institution experience.

Xiao Z, Luo G, Liu Z, Jin K, Xu J, Liu C, Liu L, Ni Q, Long J, Yu X. Xiao Z, et al. Among authors: jin k. HPB (Oxford). 2016 Feb;18(2):145-152. doi: 10.1016/j.hpb.2015.08.007. Epub 2015 Nov 17. HPB (Oxford). 2016. PMID: 26902133 Free PMC article.

9

MBD1 is an Epigenetic Regulator of KEAP1 in Pancreatic Cancer.

Zhang B, Xu J, Li C, Shi S, Ji S, Xu W, Liu J, Jin K, Liang D, Liang C, Liu L, Liu C, Qin Y, Yu X. Zhang B, et al. Among authors: jin k. Curr Mol Med. 2016;16(4):404-11. doi: 10.2174/1566524016666160316154150. Curr Mol Med. 2016. PMID: 26980696

10

VEGF Promotes Glycolysis in Pancreatic Cancer via HIF1α Up-Regulation.

Shi S, Xu J, Zhang B, Ji S, Xu W, Liu J, Jin K, Liang D, Liang C, Liu L, Liu C, Qin Y, Yu X. Shi S, et al. Among authors: jin k. Curr Mol Med. 2016;16(4):394-403. doi: 10.2174/1566524016666160316153623. Curr Mol Med. 2016. PMID: 26980697

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,024 results

Search Page

Filters